Innate Pharma

Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009 and updates on its drug candidates

March 5, 2010

Progress of clinical portfolio and strenghtnening of cash position.

Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009.
Unaudited consolidated financial statements are attached to this press release.

Innate Pharma reports operating revenue of 7.7 million euros for 2009

February 5, 2010

(IFRS unaudited provisional data)
Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) announces an operating revenue of 7.7 million euros for the year 2009. Turnover for the year amounted 3.3 million euros, including 0.5 million euros in the fourth quarter ended December 31, 2009.